Pharmacists in Stowe, PA Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Dr. Phillip David Sebrell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 180 Upland Sq Dr, Stowe, PA 19464 Phone: 610-970-0004 Fax: 610-970-0007 |
Richard Zarynow Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 180 Upland Sq Dr, Stowe, PA 19464 Phone: 610-705-0004 Fax: 610-705-0007 |
 Susan Nafus Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 180 Upland Sq Dr, Stowe, PA 19464 Phone: 610-705-0004 |
News Archive
Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18th Annual Society for Neuro-Oncology (SNO) meeting in San Francisco.
Selenium protects specialized neurons from cell death during postnatal development
Exactly 200 years ago, the Swedish scientist Jöns Jacob Berzelius discovered the trace element selenium, which he named after the goddess of the moon, Selene.
Arrayit achieves technological breakthrough in microarray production
Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.
Obama may settle for Democrat-only support to pass health reform
"President Barack Obama may rely only on Democrats to push health-care legislation through the U.S. Congress if Republican resistance doesn't eventually give way, two of the president's top advisers said," Bloomberg reports.
Radiation plus hormones offers best outcomes for localised prostate cancer
The combination of radiotherapy and androgen deprivation therapy is more effective than radiotherapy alone for preventing disease recurrence in men with localised prostate cancer, according to research findings presented at the European Society for Radiotherapy and Oncology 33rd annual congress in Vienna, Austria.
› Verified 5 days ago